Beta Bionics, Inc.
Beta Bionics, Inc. (BBNX) Stock Overview
Explore Beta Bionics, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
418.9M
P/E Ratio
-6.22
EPS (TTM)
$-1.37
ROE
-0.23%
BBNX Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Beta Bionics, Inc. (BBNX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 39.43, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $36.54.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -6.22 and a market capitalization of 418.9M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.